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Aurora Kinase-A Deficiency during Skin
Development Impairs Cell Division and Stratification
Enrique C. Torchia1, Lei Zhang1, Aaron J. Huebner1, Subrata Sen2 and Dennis R. Roop1
Aurora kinase-A (Aurora-A) promotes timely entry into mitosis, centrosome maturation, and formation of bipolar
spindles. To address the role of Aurora-A in skin development and homeostasis, we interbred a floxed Aurora-A
(Aurora-Afl) mouse with the Cre-deleter strain, K14.Cre. Aurora-Afl/fl;Krt14.Cre (Aurora-A/) mice died shortly
after birth. These mice had translucent skin, and histological evaluation showed that the dorsal skin was very thin
and fragile with frank erosions. Although the expression of the basal layer marker keratin 14 and the differ-
entiation marker keratin 1 was evident in Aurora-A/ epidermis, there was a marked reduction in the number of
suprabasal layers and basal keratinocytes. Dye exclusion assays also showed defects in barrier function. Unlike
wild-type cells, Aurora-A/ basal progenitors were delayed in forming two layers at embryonic day (E)13.5 when
embryonic skin begins to stratify. Increased numbers of mitotic cells, apoptotic bodies, and polyploid keratino-
cytes were evident in Aurora-A/ epidermis, indicating that a deficiency in Aurora-A promotes aberrant mitosis,
mitotic slippage, and cell death. Finally, Aurora-A/ keratinocytes displayed centrosomal abnormalities that
included centrosomes located at nonapical sites in basal cells. Thus, the deletion of Aurora-A in the developing
epidermis alters centrosome function of basal keratinocytes and markedly impairs their ability to divide and stratify.
Journal of Investigative Dermatology (2013) 133, 78–86; doi:10.1038/jid.2012.249; published online 26 July 2012
INTRODUCTION
Aurora kinase-A (Aurora-A) belongs to a family of conserved
mitotic serine/threonine kinases that have fundamental roles
in the regulation of cellular division. Aurora-A is found pre-
dominantly at the poles of dividing cells, localized to the
centrosomes and proximal spindles. It is required for the
timely entry into mitosis, centrosome maturation, formation of
bipolar spindles, and has been implicated in the breakdown of
the nuclear envelope and the completion of cytokinesis
(Marumoto et al., 2003; Vader and Lens, 2008). Moreover, a
role for Aurora-A was recently demonstrated in the control of
mitochondrial fission during mitosis (Kashatus et al., 2011). Its
protein stability and activity are tightly coupled to the stages
of the cell cycle, peaking at the G2/M transition and
suppressed at anaphase through protein degradation that is
mediated by the Anaphase-promoting complex (Honda et al.,
2000; Littlepage and Ruderman, 2002). Numerous interacting
factors such as AJUBA, BORA, NEDD9, PAK, PLK1, and TPX2
have been identified as important for Aurora-A’s activation
and cellular localization (Karthigeyan et al., 2011). Down-
stream targets of Aurora-A are diverse and growing (Ketten-
bach et al., 2011; Koch et al., 2011). Of these, Aurora-A can
phosphorylate the cell cycle regulator CDC25B and thereby
affect the centrosomal redistribution of CDK1–Cyclin B1
complexes to promote mitotic entry (Dutertre et al., 2004).
Aurora-A can also activate the tubulin deacetylase, HDAC6,
to regulate cilia disassembly (Pugacheva et al., 2007), and
phosphorylate NDEL1 to promote neurite extension (Mori
et al., 2009). Thus, Aurora-A has cellular functions that go
beyond its ability to regulate cell division.
Aurora-A is also a proto-oncogene that is frequently
amplified or overexpressed in epithelial cancers including
skin squamous cell carcinomas (SCCs) (Clausen et al., 2006;
Torchia et al., 2009). Aurora-A was further identified as a
low-penetrance cancer susceptibility gene in both humans
and mice (Ewart-Toland et al., 2003, 2005). Ectopic Aurora-A
expression can transform immortalized rodent cell lines
in vitro and promote their growth in immunocompromised
mice (Bischoff et al., 1998; Zhou et al., 1998). We have
previously shown in genetically engineered cancer mouse
models that Aurora-A can cooperate with a classical skin
chemical carcinogenesis protocol or with the expression of a
gain-of-function p53R172H mutant allele to promote the
formation of metastasis-prone skin SCCs (Torchia et al.,
2009, 2012). Owing to its role in cell division, Aurora-A
may be an attractive target for therapeutic intervention in
skin cancers. Currently, there are several small-molecule
inhibitors to Aurora kinase-A and -B in clinical trials
(Green et al., 2011). However, the long-term off-tumor
effects of these inhibitors remain undefined, especially in
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skin. Inhibition of Aurora-A activity in cultured cells results
in mitotic abnormalities, misalignment of chromosomes,
and growth suppression (Barr and Gergely, 2007). Recently,
three different laboratories have described the global
deletion of Aurora-A in mice (Lu et al., 2008; Sasai et al.,
2008; Cowley et al., 2009). In these reports, deletion of
Aurora-A resulted in embryonic death before implantation
(Lu et al., 2008; Sasai et al., 2008; Cowley et al., 2009).
From these studies, it is clear that Aurora-A is essential for
life, but the early lethality of these mice precluded the
study of Aurora-A’s function in tissue-specific development or
homeostasis. In the present study, we examined the
consequences of keratinocyte-specific deletion of Aurora-A
to determine its role in the formation and maintenance of skin
epithelia.
RESULTS
Skin-specific deletion of Aurora-A
To delete Aurora-A in skin, we interbred floxed Aurora-A
mice (Sasai et al., 2008) with a constitutively active Cre
recombinase expressed from a truncated keratin 14 promoter
(K14.Cre) (Dassule et al., 2000). This Cre deleter strain begins
to express Cre in epithelial tissues at embryonic day (E)10.5
and displays Cre activity more uniformly by E12.5 as shown
by the activation of the Rosa26 b-galactosidase Cre reporter
(Supplementary Figure S1a online). Aurora-Afl/þ ; K14.Cre
mice appeared phenotypically normal. In contrast, Aurora-
Afl/fl; K14.Cre mice died shortly after birth, and had obvious
skin-related abnormalities including fragile, translucent,
and stretched skin, the failure of eyelids and ears to form
normally, fused fingers, and the absence of whisker follicles
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Figure 1. Skin abnormalities in mice deficient for epithelial Aurora-A. (a) Left panels show gross phenotypic presentation of Aurora-Afl/fl; K14.Cre mice at
embryonic day (E)18.5. These mice show translucent skin compared with wild-type (WT) controls. Right panels show a close-up of the face and paws. Note the
improperly formed whiskers, nares, eyelids, and nails. (b) Toluidine blue dye penetration assays revealed a defect in barrier function in Aurora-Afl/fl; K14.Cre
E18.5 mice. (c) Tails from newborn mice were digested and PCR performed to detect Cre-mediated recombination of the floxed Aurora-A allele. Bars¼ 2.5mm.
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(Figure 1a). Moreover, toluidine penetration assays in E18.5
embryos revealed defects in skin barrier function, which were
more pronounced on the ventral side of the embryos (Figure
1b). Detection of the recombined floxed allele was evident in
the skin of both Aurora-Afl/þ ; K14.Cre and Aurora-Afl/fl;
K14.Cre newborn mice (Figure 1c and Supplementary Figure
S1b online). Deletion of the floxed allele was associated with
reduced Aurora-A mRNA levels in whole skin (Supplemen-
tary Figure S2a online) and the absence of detectable Aurora-
A protein in actively dividing keratinocytes of Aurora-Afl/fl;
K14.Cre embryos (Supplementary Figure S2b online). Collec-
tively, these observations indicate that a defective skin
barrier, caused by epidermal Aurora-A deficiency, most
likely led to desiccation and perinatal lethality of Aurora-
Afl/fl; K14.Cre newborn mice.
Histological evaluation of the skin of Aurora-Afl/fl; K14.Cre
mice at E16.5 and older showed a thin epidermis and the
absence of mature hair follicles (Figure 2). We focused on the
interfollicular keratinocyte compartment for the remainder of
this study. The nuclei of the Aurora-A/ keratinocytes
appeared enlarged with multiple nucleoli. Marker analysis
revealed the expression of keratin (Krt)1 and 10 in the
suprabasal compartment, whereas Krt14 and Krt5, and the
stress keratin Krt6, were evident in the basal layer of Aurora-
Afl/fl; K14.Cre dorsal skin (Figure 2). The late differentiation
markers, loricrin and filaggrin, were also detectable in the
outermost layer of Aurora-A/ epidermis. However, the
expression of filaggrin was markedly reduced or sporadic
(Figure 2). A similar pattern of expression was observed for
Krt1 on the ventral side of E17.5 Aurora-Afl/fl; K14.Cre
embryos, whereas loricrin and filaggrin expression was
markedly reduced or absent (Supplementary Figure S3
online). The lack of loricrin and filaggrin expression on the
ventral side likely contributed to a more severe impairment of
barrier function in Aurora-Afl/fl; K14.Cre embryos (see Figure
1b). Both collagen IV and integrina6 were found at the
epidermal–dermal junction of Aurora-A-deficient epidermis,
and we observed an expression pattern similar to wild-type
(WT) for the adherent junction proteins Zo-1, desmoglein 1/2,
and desmocolin3 (data not shown). Thus, Aurora-A defi-
ciency did not disrupt the integrity of the basement
membrane, or cellular junctions of the epidermis.
Delayed stratification of Aurora-A/ skin epithelia
The phenotypic presentation and abnormal epidermal
architecture of Aurora-Afl/fl; K14.Cre prenatal mice suggested
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Figure 2. Aurora-Afl/fl;Krt14.Cre (Aurora-A/) epidermis exhibits a disrupted epidermal architecture. Histological analysis (hematoxylin and eosin
(H&E)) of Aurora-A/ dorsal skin at embryonic day 16.5 revealed a thin epidermis and the absence of mature hair follicles. However, marker analysis showed
the presence of a basal layer by the detection of keratin 14 (Krt14) expression, whereas expression of Krt1 marked the presence of the suprabasal compartment.
A similar pattern was observed for Krt10/Krt 5 expression (not shown). The late differentiation markers, loricrin and filaggrin, were visible in the outermost part of
Aurora-A/ epidermis. DAPI, 4’,6-diamidino-2-phenylindole. Bar¼25 mm.
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that Aurora-A deficiency may impair the formation of the
stratified layers of the skin. We therefore examined the
embryonic stages between E12 and 14, when the epithelium
stratifies to create the suprabasal compartment (Koster and
Roop, 2007). Unlike WT cells, Aurora-A/ epidermal
progenitors were delayed in forming a suprabasal layer in
both the ventral and dorsal skin, as evident by histological
evaluation and the late appearance of Krt1-expressing cells
(Figure 3a). Because suppression of proliferation could
account for a delay in the emergence of suprabasal
keratinocytes, we examined the S and M phases of the cell
cycle in developing skin. At E13.5, similar numbers of
keratinocytes in both WT and Aurora-A/ epidermis
were positive for bromodeoxyuridine (BrdU) incorporation,
indicating that Aurora-A deficiency did not alter the ability of
keratinocytes to enter S phase (Figure 3c). Next, we stained
for phospho-histone H3 to determine the relative number of
cells in mitosis (Tapia et al., 2006). As shown in Figure 3b and
c for WT epidermis, only a few basal and suprabasal layer
cells were positive for phospho-histone H3, consistent with a
short duration spent tranversing M phase (Dover and Potten,
1988). In contrast, a much higher number of positive cells
were found in Aurora-A/ versus WT skin (a 3- and 6-fold
increase in the dorsal and ventral epidermis, respectively).
Furthermore, mitotic cells in Aurora-A/ epidermis lacked a
fully formed nuclear envelope as shown by a diffused staining
pattern for Lamin A/C, a nuclear membrane structural com-
ponent (Margalit et al., 2005) (Supplementary Figure S4
online). As the nuclear envelope is disassembled before
metaphase in mitosis (Margalit et al., 2005), Aurora-A-
deficient keratinocytes appear to stall at prometaphase of
the cell cycle.
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Figure 3. Delayed stratification in Aurora-Afl/fl;Krt14.Cre (Aurora-A/) epidermis. (a) The epidermis between E13 and 14 was examined by histology
and marker analysis. Unlike wild-type (WT) epidermis that forms two layers at E13.5, Aurora-A/ epidermis remains primarily a single layer. Consistently,
few cells expressed the suprabasal marker keratin 1 (Krt1) in the uppermost layer of the skin. A similar pattern was observed on ventral skin (not shown).
(b) Immunofluorescent detection of phopho-histone H3 (pHistoneH3; Ser10) in E13.5 skin. Note the increased number of positive cells found in both dorsal and
ventral skin of Aurora-Afl/fl; K14.Cre mice. (c) Quantification of BrdU incorporation and detection of mitotic cells per Krt14-positive keratinocytes. Data shown
are the average counts per three embryos±SD. P-values are from a t-test. DAPI, 4’,6-diamidino-2-phenylindole; H&E, hematoxylin and eosin. Bar¼ 25 mm.
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The outcome of a stalled mitosis in Aurora-A/ keratinocytes
Cells that are stalled in mitosis can undergo cell death or
escape without completion of cytokinesis by a process called
mitotic slippage (Rieder and Maiato, 2004). To determine
whether apoptosis was a consequence of deleting Aurora-A
in keratinocytes, we stained Aurora-A/ epidermis for the
apoptotic marker active caspase 3. Unlike WT skin, active
caspase 3 was readily detectable in Aurora-A/ epidermis.
Its detection peaked at E13.5, which coincided with the
commencement of stratification (Figure 4). Another
outcome of a delayed mitosis is the failure to generate two
daughter cells, leaving the cell with twice the normal
complement of genetic material. To test this possibility,
we enumerated centromeres by staining paraffin sections
of embryonic skin with a pan-centromere fluorescence
in situ hybridization probe. Increased numbers of centro-
meres were found in Aurora-A/ epidermis relative to the
nuclei found in WT epidermis or in the dermis of Aurora-Aflfl;
K14.Cre mice that remained WT for Aurora-A (Figure 5).
Moreover, cells in metaphase or anaphase were rarely observed
by histology or by staining with Aurora-B, which localizes to the
midzone or anaphase bridges during mitosis (Ruchaud et al.,
2007) (data not shown). From these analyses, we conclude
that Aurora-A/ keratinocytes gave rise to polyploid cells.
Centrosome abnormalities in Aurora-A/ keratinocytes
Aurora-A promotes the maturation of centrosomes and
formation of bipolar spindles in preparation for cell division
(Vader and Lens, 2008). Therefore, we examined how
Aurora-A deficiency affected centrosome function in the
developing epidermis. In WT keratinocytes at E16.5 and
older, the centrosomes were predominately found apically
(Figure 6a, arrows). This orientation was altered in Aurora-A/
epidermis, with the position of the centrosomes becoming
random and located either apically, basolaterally, or centrally
(Figure 6a, arrows, and see Supplementary Figure S5 online).
As shown in Figure 6b, there were multipolar structures or
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Figure 4. Increased apoptosis in Aurora-A-deficient epidermis. Top panel
shows the immunodetection of active caspase 3 in wild-type (WT) and
Aurora-Afl/fl;Krt14.Cre (Aurora-A/) epidermis at E13.5. Bottom panel shows
the quantification of apoptosis found in developing skin of Aurora-Afl/fl;
K14.Cre or WT embryos (n¼ 2 embryos per genotype and time point).
Columns represent average±SD. Note the absence of apoptotic cells in WT
skin at any embryonic stage. DAPI, 4’,6-diamidino-2-phenylindole; d.c.p.,
days post coitum. Bar¼25 mm.
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Figure 5. Aurora-A deficiency induces polyploidy in keratinocytes. Left panels show the representative fluorescence in situ hybridization detection of
a pan mouse centromere probe on 5-mm-thick paraffin sections from E16.5 skin of Aurorafl/fl and Aurora-Afl/fl; K14.Cre embryos. Right, quantification of
centromeres. Mean count±SD is shown. Note the consistent number of centromeres in cells found in wild-type Aurora-A epidermis or the dermis of
Aurora-Afl/fl; K14.Cre mice that do not undergo Cre recombination. However, much higher numbers are detected in Aurora-Afl/fl;Krt14.Cre (Aurora-A/)
epidermis, indicative of polyploidy. DAPI, 4’,6-diamidino-2-phenylindole. Bar¼ 10mm.
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centrosome clusters in Aurora-A/ epidermis, reminiscent of
spindle anomalies observed in cells with extra centrosomes
(Ganem et al., 2009) or those treated with Aurora-A
inhibitors, and in Drosophila mutants of Aurora-A (Glover
et al., 1995; Manfredi et al., 2007). Since the proper
orientation of centrosomes is required for the formation of
bipolar spindles in preparation for metaphase, we next
examined the microtubule network in Aurora-A/ epider-
mis. In actively dividing WT cells, microtubules are
organized between two opposing nucleating poles (i.e., the
centrosomes) whose orientation to the basement membrane
determines the plane of cell division (Glotzer, 2009). A basal
cell that forms a bipolar spindle perpendicular to the
basement membrane will divide asymmetrically and give
rise to two cells, a suprabasal and a basal keratinocyte (Figure
6c) (Smart, 1970; Lechler and Fuchs, 2005). In Aurora-A/
keratinocytes, basal cells with bipolar spindles were rarely
observed at E13.5 or at later embryonic stages. In dividing
cells identified by phospho-histone H3 expression, the
microtubule network appeared disorganized (Figure 6c).
Taken together, these data indicate that abnormal centrosome
function induced by the deletion of Aurora-A leads to a
defective cellular division and the mislocation of centro-
somes following mitosis of basal cells.
To determine whether the effects of Aurora-A deficiency
were similar in postnatal skin, Aurora-A-floxed mice were
crossed with the tamoxifen (Tam)-inducible Cre deleter
strain, K14.CreER (Vasioukhin et al., 1999). This Cre fusion
shows robust deletion of floxed alleles in keratinocytes both
in vitro and in vivo after treatment with Tam (Supplementary
Figure S6a online). Similar to Aurora-Afl/fl; K14.Cre embryos,
Aurora-A was not detectable in dividing keratinocytes present
in the skin of Tam-treated Aurora-Afl/fl; K14.CreER mice
(Supplementary Figure S6b online). Surprisingly, the deletion
of Aurora-A in postnatal epidermis resulted in no obvious
gross skin abnormalities (e.g., hair loss or skin erosions)
3 months following the induction of Cre activity by Tam
treatment (n¼ 6 and data not shown). We were able to detect
cells that were positive for phospho-histone H3 or active
caspase 3 in Aurorafl/fl; K14.CreER epidermis 10 days after the
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Figure 6. Centrosomal abnormalities in Aurora-Afl/fl;Krt14.Cre (Aurora-A/) epidermis. (a) The location of centrosomes was examined in Aurora-A/
E16.5 epidermal skin by immunostaining with g-tubulin. Left panels show the apical location of centrosomes (arrows) in basal keratinocytes, relative to
the basement membrane. Right panels show nonapical locations of centrosomes in Aurora-A/ epidermis (arrows). Bar¼ 25 mm. (b) Higher magnification
of Aurora-A/ cells. Bar¼ 10 mm. (c) Detection of the microtubule network by a-tubulin immunostaining. Left panel shows formation of a bipolar spindle
in a WT keratinocyte undergoing mitosis. Right panels show atypical microtubule formation in Aurora-A/ basal cells, reminiscent of monopolar spindles.
Bar¼5 mm. DAPI,4’,6-diamidino-2-phenylindole; pHistoneH3, phopho-histone H3.
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induction of Cre (Supplementary Figure S7 online); however,
adult epidermis appears to be reasonably tolerant to the
deletion of Aurora-A.
DISCUSSION
In the present study, we utilized a conditional deletion
strategy to demonstrate that the expression of Aurora-A is
required for normal skin development. The deletion of
Aurora-A in embryonic basal keratinocytes resulted in
defective centrosome maturation, which markedly impaired
the ability of these cells to divide and stratify. Consequently,
the initiation of stratification and differentiation was delayed
in the developing Aurora-A/ epidermis, resulting in
impaired barrier function and perinatal death. Previous
studies have shown that barrier formation begins on the
dorsal epidermis and progresses laterally starting at E16
(Hardman et al., 1998). The ventral epidermis is last to
acquire a competent barrier. The incorporation and cross-
linking of epidermal differentiation proteins such as loricrin
into the cornified envelope coincides with the formation of
barrier function (Simpson et al., 2011). In Aurora-A-deficient
epidermis, barrier formation is defective, leading to a
phenotype that is especially prevalent on ventral skin.
Nevertheless, dorsal skin in Aurora-Aflfl; K14.Cre embryos
was able to express terminal differentiation proteins and form
a partial barrier, whereas the ventral epidermis was not. How
dorsal skin is able to form two layers and undergo
differentiation in light of an obvious cell cycle defect in
basal keratinocytes is unclear. It is possible that incomplete
Cre recombination of both floxed Aurora-A alleles between
E12.5 and 13.5 or residual Aurora-A mRNA allowed enough
basal progenitors to undergo at least one round of cellular
division. Alternatively, basal delamination of nonmitotic cells
may contribute to the formation of the first suprabasal layer in
Aurora-Afl/fl; K14.Cre skin (Magee et al., 1987; Adams and
Watt, 1990; Poumay et al., 1994; Liebig et al., 2009;
Connelly et al., 2010).
The phenotypic consequence of deleting Aurora-A in
mouse keratinocytes is reminiscent of the effects of expres-
sion of Aurora-A mutants in Drosophila (Glover et al., 1995;
Berdnik and Knoblich, 2002). Drosophila mutations in
Aurora-A result in lower expression of the mutant protein
compared with WT flies. The most penetrant of these mutants
induced monopolar spindles in dividing cells, delays in
mitosis, and polyploidy (Glover et al., 1995; Berdnik and
Knoblich, 2002). Invariably, the failure of centrosomes to
separate before metaphase can explain the effects
of suppressing Aurora-A levels in flies. The deletion of
Aurora-A in the developing mouse skin mirrored the most
severe of the Drosophila mutants, resulting in centrosomal-
related defects. In addition, the centrosomes in Aurora-A/
basal cells appeared to lose the predominant apical place-
ment seen in WT keratinocytes (Lechler and Fuchs, 2007) and
were found to be distributed more randomly. The position of
centrosomes, which determines the axis of cell division
during mitosis, is set during metaphase in basal keratinocytes
(Adams, 1996; Poulson and Lechler, 2010). In the stages that
precede metaphase, centrosomes can be found at angles
between parallel and perpendicular (0–90o) relative to the
basement membrane (Poulson and Lechler, 2010). The
observed locations of the centrosomes in Aurora-A/
keratinocytes may be a consequence of these cells stalling
in prometaphase, undergoing mitotic slippage, and possibly
reentering the cell cycle.
Surprisingly, the postnatal deletion of Aurora-A resulted
in no gross skin defects, suggesting that the inhibition of
Aurora-A activity may be well tolerated by adult skin, and
represents a clear distinction to the effects observed on the
prenatal epidermis as we show in this study, or that seen in
early-stage embryos (Lu et al., 2008; Sasai et al., 2008;
Cowley et al., 2009). Our observations are also consistent
with recent clinical trials of Aurora-A small-molecule
inhibitors that have shown increased phosho-histone H3
staining in the skin, but the absence of reported skin-related
toxicities (Chakravarty et al., 2011). The mechanism that
allows adult skin to tolerate Aurora-A deletion remains
unclear but may depend on the relative higher rate of
proliferation observed in embryonic versus adult skin. In this
regard, Aurora-A inhibition would be expected to have a
more profound effect on skin cancer cells, which have a
higher rate of proliferation (Torchia et al., 2009), and be more
similar to what we observed in embryonic keratinocytes.
More importantly, our data suggest that the use of small-
molecule inhibitors of Aurora-A may be a safe and viable
strategy to treat recurrent or metastasis-prone skin SCCs
(Ganem et al., 2009) if topical delivery of inhibitors can be
achieved.
In summary, we have characterized the cellular and
tissue-specific changes associated with Aurora-A deficiency
in the developing epidermis. Aurora-A-deficient epidermis
may be an ideal model to explore the relationship between
the regulation of cell division, migration, and differentiation
in epidermal homeostasis, and a tool to develop new
approaches to maximize the killing of SCC cells by targeting
mitotic regulators.
MATERIALS AND METHODS
Generation of Aurora-A-deficient epidermis
The previously described floxed Aurora-A(fl) mice (Sasai et al., 2008),
K14.Cre mice (Dassule et al., 2000) or K14.CreER mice (Vasioukhin
et al., 1999) were interbred to generate Cre-positive and hetero-
zygous or homozygous Aurora-Afl mice. Timed matings were set up
at night and the presence of vaginal plugs on the following morning
noted as day 0. Embryos were then collected at days corresponding to
different mouse developmental stages. The University of Colorado
Institutional Animal Care and Use Committee approved animal
experiments. Detection of the Cre-recombined floxed Aurora-A allele
was performed as previously described (Sasai et al., 2008). For
experiments using the K14.CreER strain, mice were topically treated
with 125mg of 4 hydroxytamoxifen (Sigma, St Louis, MO) dissolved
in ethanol or injected intraperitoneally for 6 days with tamoxifen
(Sigma) (6mg per 40 g body weight) dissolved in sesame oil.
Dye penetration and quantitative PCR assay
Dye penetration was tested on E18.5 embryos as previously
described (Hardman et al., 1998). Briefly, embryos were dehydrated
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and rehydrated through a series of methanol washes and
subsequently incubated in phosphate-buffered saline solution
saturated with toluidine blue (Sigma). RNA isolation, reverse
transcription, and quantitative PCR analysis was performed as
previously described (Torchia et al., 2009). Aurora-A mRNA was
detected by Taqman assay# Mn01248177_m1 (Life Technologies,
Grand Island, NY) and normalized to Gapdh (Life Technologies)
levels.
Histology, immunostaining, and b-galactosidase staining
Mouse tissues were fixed in 10% neutral-buffered formalin (Thermo
Fisher Scientific, Pittsburgh, PA), and embedded in Optimal Cutting
Temperature compound (Sakura Finetek, Torrance, CA) for frozen
sectioning or processed for paraffin sectioning. The cut planes were
either sagittal at the midline or transverse at the midbody. For
histological evaluation, dewaxed 5-mM sections were stained with
hematoxylin and eosin. Immunostaining was performed as pre-
viously described with modifications (Torchia et al., 2009). Briefly,
paraffin-embedded tissue was dewaxed and antigen retrieval
performed using a Tris EDTA solution, pH 10, containing 0.05%
Tween20. Sections were then blocked and incubated with the
following primary antibodies: Krt1, 5, 10, 14, loricrin and filaggrin
(Roop et al., 1984; Yuspa et al., 1989), Col IV (Abcam, Cambridge,
MA), Ita6 (EMD Millipore, Billerica, MA), g-tubulin (Abcam),
a-tubulin (Sigma), phospho-histone H3 (Ser 10) (Cell Signaling,
Danvers, MA), and Active Capase 3 (Cell Signaling). Appropriate
secondary antibodies labeled with Alexa488 or 594 were applied
and sections mounted on Vectashield Mounting Medium containing
4’,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlin-
game, CA). Staining detection was performed on a Nikon 90i
microscope (Nikon, Melville, NY) using standard techniques. For
BrdU in vivo labeling experiments, mice were injected with BrdU
(Sigma) as previously described (Torchia et al., 2007). Tissue was
then harvested after 2 hours, fixed, embedded in paraffin, and
stained as described above using rat anti-BrdU antibody (Abcam).
Staining for b-galactosidase (X-gal) activity was performed on 10-mm
Optimal Cutting Temperature compound (Sakura Finetek) sections as
previously described (Torchia et al., 2007).
Fluorescence in situ hybridization
Fluorescence in situ hybridization detection and enumeration of
mouse centromeres was conducted at the University of Colorado
Cancer Center Cytogenetic Core. Briefly, dewaxed sections
were hybridized with SpectrumRed-labeled Poseidon. All Mouse
Centromere Probe (KI-30500, Kreatech Diagnostics, Durham,
NC). Chromatin was counterstained with DAPI (Vectashield
Mounting Medium, Vector Laboratories). Analysis was performed
using an epifluorescence microscope using single interference
filter sets for red (Texas red), blue (DAPI), and triple (blue, red,
green) band-pass filters. The number of signals was scored in at
least 30 nuclei per selected area in each specimen. Images were
acquired and merged using CytoVision application (Leica Micro-
systems, Buffalo Grove, IL).
Cell counting and statistical analyses
To enumerate the number of % keratinocytes that were positive for
BrdU or phospho-histone H3, three separate embryos of each
genotype were analyzed. Tissue sections from dorsal and ventral
skins at E13.5 were stained for either BrdU incorporation/Krt14 or
phospho-histone H3/Krt14. The number of BrdU- or phospho-
histone H3–positive cells were scored at  200 magnification after
counting on average 294 and 575 Krt14–positive keratinocytes/
embryo, respectively. Similar analysis was performed for active
caspase 3–/Krt14–stained tissue sections with an average of 587
Krt14–positive cells/embryo counted. Dorsal skin was analyzed in
two separate embryos for each embryonic time point. Statistical tests
shown in Figure 5c (phosho-histone H3) were performed using
GraphPad Prism v5 (Graph Pad Software, La Jolla, CA).
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